Perspective · 27 Sep 2024
Conference abstractPublished 15 Aug 2011
Variability in carcinogen metabolism
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cigarette smoke consists of thousands of constituents. Some of these e.g. 4-aminobiphenyl and 4-(Methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK) have been identified by the International Agency for Research on Cancer (IARC) as human carcinogens (IARC Group 1 carcinogens). Exposure to cigarette smoke constituents can occur through many other sources in addition to cigarette smoke. The systemic exposure for these constituents depends primarily on their absorption, distribution, metabolism and excretion (ADME). Of the ADME processes, metabolic activation and detoxification plays a significant role in determining the systemic exposure. A substantial proportion of the differences in metabolism can be accounted by induction or inhibition as well as genetic polymorphisms of the metabolic enzymes. There is abundant evidence on the allelic variants for the different enzymes involved in the metabolism of these carcinogens. The tobacco specific nitrosamine, NNK undergoes carbonyl reduction to NNAL (4-methylnitrosamino-1-(3-pyridyl)-1-butanol) by the CYP450 enzyme, CYP2A6, that exhibits genetic polymorphisms. NNAL undergoes subsequent glucuronidation through the glucuronyl transferases, UGT1A4 and UGT2B10. The UGT2B10 Asp67Tyr allele has been linked to a haplotype associated with decreased N-glucuronidation of NNAL. Similarly, allelic differences in CYP1A2 and N-acetyltransferase enzymes have also been attributed to variations in 4-aminobiphenyl metabolism. The composite effect of the phenotypic outcome of the individual genotypic differences and its subsequent impact on systemic exposure has not been methodically characterized. Such an assessment is possible by determining the metabolite ratios as well as measuring the overall exposure as estimated from urinary excretion. Data from a stratified, multi-center, cross-sectional study of 3,585 adult smokers and 1,077 non-smokers were analyzed to characterize the variability in carcinogen metabolism. The different sources of variability in carcinogen exposure will be discussed in this presentation.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2020
N-nitrosodimethylamine induced changes in the activities of carcinogen-metabolizing enzymes in the liver of male mice: role of glutathione and gossypol as antioxidants
Review article · 2015
Metabolic Changes of Aflatoxin B1 to become an Active Carcinogen and the Control of this Toxin
Editorial · 1 Apr 2013
Genetic and Metabolic Effects of Chemical Carcinogens: A Complex Interplay
Research article · 31 Jan 2011
Elucidation and Validation of Metabolic Activation of Human Mammary Carcinogen Dibenzo[a,l] pyrene and its Metabolites Using In silico Approach
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Mohamadi Sarkar”

